Search results 1-1 of 1 in Anemia
Results
-
Rochester, Minn.
View Summary
Allogeneic Stem Cell Transplantation for Patients With Severe Aplastic Anemia
Location:
Rochester, Minn.
Trial status:
Open for Enrollment
Why is this study being done?
The objective of this trial is to make an initial assessment for this new treatment regimen and to show it is equal or superior to the current standard practice. With this initial assessment be hope to gain information suggesting further study of this regimen or discontinuation of this regimen before exposing large numbers of patients to this new treatment option. We also will gain experience with this new regimen giving insights as to possible modifications in dosing and monitoring and selection of patients for future treatment in case of positive results. For this initial study we plan to enroll up to 24 patients.
NCT ID:
NCT00578266
IRB Number:
06-006216
Who can I contact for additional information about this study?
Rochester: Shakila Khan, MD 507-284-3442